werdalnajim Profile Banner
Werd Al-Najim Profile
Werd Al-Najim

@werdalnajim

Followers
580
Following
455
Media
47
Statuses
341

Registered Dietitian PhD | EU Research Project Manager | Special interest in Obesity Management and Education

Dublin City, Ireland
Joined May 2017
Don't wanna be here? Send us removal request.
@werdalnajim
Werd Al-Najim
8 months
Slides ready for #IrSPEN2025 ✅Excited to present in Session 5: Metabolic/Obesity alongside @DrMCrotty, @HeneghanHelen, and @carel_leroux. We'll be diving into how dietitians can support patients on pharmacotherapy for obesity — see you there! @IrSPEN
0
3
13
@IrSPEN
IrSPEN
8 months
REGISTER NOW to hear Niamh Rice provide new insights into the current prevalence and cost of malnutrition in Ireland. In 2011, adults over 65 made up just 11.4% of the population. Ireland is now experiencing the fastest rate of population aging in Europe https://t.co/uyz2GNOpz7
0
7
12
@IrSPEN
IrSPEN
1 year
IrSPEN CONFERENCE 2025! We are delighted to announce that REGISTRATION IS NOW OPEN - Tuesday 8th April 2025 at the Aviva Stadium https://t.co/ZnY3ZJ2TZ9
0
2
6
@imisophia
imisophia
1 year
"A complex lived experience" - @Deemcgillicuddy speaks with @werdalnajim from @ucddublin about the importance of the patient experience in obesity research and how this helps us improve obesity care 💚 Find out more here https://t.co/ko3ZD5sVR8
0
2
6
@carel_leroux
Carel Le Roux
2 years
Let's not repeat past errors by assuming GLP-1 analogues alter food preferences without solid evidence. Verbal reports aren't enough; we need direct behavioural measures 💡➡️ https://t.co/ZgZFskYGg9
Tweet card summary image
link.springer.com
International Journal of Obesity - Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities
0
7
20
@PeerVoice
PeerVoice
2 years
Carel le Roux, MD, PhD discusses building a better approach to obesity care #obesity #endocrinology #MedEd #PeerVoice https://t.co/Gas7Ww5cTb
0
4
8
@werdalnajim
Werd Al-Najim
2 years
Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial https://t.co/z5aUTvup0y
2
4
12
@werdalnajim
Werd Al-Najim
2 years
🌟 Exciting Opportunity for a Passionate Physiotherapist! 🌟 🔍 Position: Part-Time Physiotherapist 📍 Location: Bray, Ireland https://t.co/8FC0FBs4AZ
0
0
0
@notyourfaultie
Its Not Your Fault
2 years
EASD 2023 - Interview with @carel_leroux about bariatric surgery and weight lowering drugs https://t.co/tlTSZ7T6m1
0
5
7
@AlexanderMiras
Alex Miras
2 years
Join us for this interesting series of presentations. Obesity Management: From Strategy to Practice
mynutriweb.com
Online symposium for health professionals, tutors & students discussing the latest updates in obesity management and what this means for practice
0
7
19
@HospitalProNews
Hospital Professional News
2 years
The December edition of Hospital Professional News is available to read online. Featuring our annual Professional 100 Listing and End of Year Reviews, looking back at the challenges and achievements of 2023 View the December magazine here: https://t.co/hxwv5CzSA3
0
5
26
@imisophia
imisophia
2 years
Are you looking for an opportunity to apply your #programming and #dataanalysis skills to increase the understanding of and optimise future #obesitytreatment? Join SOPHIA as a Data Science PostDoc! Read more about the position, and who to contact here: https://t.co/2FJ8uI0m3B
0
4
6
@IrishResearch
We are now Research Ireland
2 years
IRC Researcher of the Year 2023 Professor Carel le Roux collects his trophy from IRC Director Peter Brown. Many congratulations, Carel! @carel_leroux @scienceirel @UCD_Research #LoveIrishResearch
8
10
73
@ucddublin
University College Dublin
2 years
👨‍🏫🏆 UCD Professor Carel Le Roux named 2023 IRC Researcher of the Year 🔹 Professor Emma Teeling ‘highly commended’ in Researcher of the Year category The Irish Research Council has named Professor Carel Le Roux Researcher of the Year for 2023. A leading clinical scientist and
2
14
43
@werdalnajim
Werd Al-Najim
2 years
💡Read @imisophia's most recent paper ➡️ https://t.co/3lAmRWR4ac
@imisophia
imisophia
2 years
How can we change the narrative in obesity treatment and care? Read this article to find out how the @imisophia project views #obesity as a set of different diseases as it aims to create more personalized treatment: https://t.co/VfSiXBxyqh
0
0
1
@werdalnajim
Werd Al-Najim
2 years
I look forward to co-hosting this webinar on "Navigating Nutrition When Taking Anti-Obesity Medications: To Diet or Not to Diet?" with my colleague Hazel Windsor-Aubrey as part of our work in @beyondbmi. 📅 Friday 10 November 📝
luma.com
In this webinar, you'll gain valuable insights into how nutrition plays a pivotal role when utilizing anti-obesity medications. Dr. Werd and Hazel will provide…
0
1
2
@werdalnajim
Werd Al-Najim
2 years
0
0
1
@ConscienHealth
Ted Kyle
2 years
Feeling fortunate to spend two days in DC with these amazing people as part of the International Obesity Collaborative aiming to align on clear and meaningful communication about the complex, chronic disease of #obesity.
4
13
50
@UCD_Research
UCD Research
2 years
A new AI driven prediction tool allows patients and their doctors to accurately predict weight loss over 5 years following bariatric surgery. Supported by the @UCDMedicine led SOPHIA @imisophia, the research was published in @TheLancet. ➡️ https://t.co/QiH61UNNEq
0
7
11
@werdalnajim
Werd Al-Najim
2 years
Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study - The Lancet Digital Health https://t.co/nAkYEHcfw8 @imisophia
Tweet card summary image
thelancet.com
We developed a machine learning-based model, which is internationally validated, for predicting individual 5-year weight loss trajectories after three common bariatric interventions.
0
0
3